KRTL BioTech

Latest News on private equity markets

Aurora Cannabis to take C$1 billion in charges, cuts 500 jobs as CEO exits

Aurora Cannabis said Chief Executive Terry Booth will retire and Executive Chairman Michael Singer become interim CEO as the beleaguered marijuana producer announced C$1 billion ($752.79 million) in impairment charges on Thursday.



4 years ago

Hedge fund Elliott Management builds $3 billion stake in SoftBank: sources

Hedge fund Elliott Management Corp, one of the world's most powerful activist investors, has amassed a nearly $3 billion stake in SoftBank Group Corp and is pushing for changes to boost the Japanese conglomerate's value, sources said.



4 years ago

Rally in stocks runs out of steam as coronavirus toll climbs

A mid-week rally in Asian share markets halted on Friday and oil prices steadied as the growing death toll and economic damage from a new virus spreading from China curbed further gains.



4 years ago

ViacomCBS to launch new streaming platform: source

ViacomCBS is working on a streaming service that will build on CBS All Access, a person familiar with the matter said on Thursday.



4 years ago

South Korea asks China for help in resuming production at auto parts plants

The South Korean government said on Friday it has asked Chinese regional governments for help in resuming production at South Korean auto parts suppliers' factories in China.



4 years ago

Boeing's botched Starliner test flirted with 'catastrophic' failure: NASA panel

Boeing narrowly missed a "catastrophic failure" during its December flight test of an unmanned space taxi that was cut short by an unrelated problem, a NASA safety review panel said Thursday, recommending that the agency examine Boeing's software verification process before letting it fly humans to space.



4 years ago

Toyota keeps China plant output stopped through Feb. 16 as virus hits supply, logistics

Toyota Motor Corp on Friday said production at all of its China plants would remain suspended through Feb. 16, joining a growing number of automakers facing stoppages due to supply chain issues as the coronavirus spreads.



4 years ago

Honda to keep vehicle plants in Wuhan suspended through Feb. 13

Honda Motor Co said Friday it will keep operations at its vehicle plants in Wuhan, China, suspended through Feb. 13, as previously planned.



4 years ago

Trump, Xi reaffirm backing for Phase 1 of U.S.-China trade deal

U.S. President Donald Trump expressed confidence in China's strength and resilience in confronting its coronavirus outbreak during a conversation with President Xi Jinping on Thursday, a White House spokesman said.



4 years ago

Exclusive: Goldman Sachs to raise $8 billion for new buyout fund - sources

Goldman Sachs Group Inc plans to raise $8 billion in only its second buyout fund since the 2008 financial crisis, bolstering its ability to secure deals worldwide, said two people with direct knowledge of the matter.



4 years ago

Huawei launches legal action against Verizon alleging unauthorized patent use

China's Huawei Technologies Co Ltd has launched legal action against Verizon Communications Inc , alleging the U.S. carrier used 12 of its patents without authorization.



4 years ago

Mitsubishi postpones first SpaceJet delivery for at least another year

Japan's Mitsubishi Aircraft Corp said on Thursday it will delay the first delivery of its SpaceJet regional jet for at least another year until after March 2021.



4 years ago

Stocks gain after China cuts trade tariffs, solid U.S. data

Asian stocks edged up on Thursday, cheered by record closes in Wall Street benchmarks after encouraging economic data, and after China announced a cut in tariffs on some imported goods from the United States.



4 years ago

Toyota lifts annual profit forecast on currency moves, three-quarter profit eases

Toyota Motor Corp on Thursday raised its forecast for annual operating profit by 4.2% due to a slightly weaker yen, while it also expects to sell more vehicles than an earlier estimate.



4 years ago

Sanofi eyes more growth this year as it narrows focus

Sanofi on Thursday said it was expecting earnings per share to grow around 5 percent at constant exchange rates in 2020, weeks after pledging to focus on vaccines and key treatments like its eczema medicine Dupixent until 2022.



4 years ago